NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The burden of proof for something like this should be different.

The key is the safety profile.

The risk to reward ratio is a no-brainer.

Except for the money, the patients have literally nothing to lose by trying Direct, especially since they can't tolerate SOC anyway.

One day, we're going to be asking why it took so long to approve DCVax and why so many lives had to be lost that could have been saved.